Amnion Full Thickness Double Layer
AmnioLink® & AmnioForm — A Breakthrough in Amniotic Matrix Regenerative Applications
AmnioLink®, developed by ECM Biomedical, is an advanced regenerative biomaterial derived from healthy, full-term placentas donated after childbirth. It utilizes the most bioactive and nutrient-rich components of the amniotic membrane, umbilical cord, and chorionic membrane. The extracted amniotic matrix contains over 200 types of growth factors, cytokines, and anti-inflammatory molecules, and features a naturally preserved three-dimensional scaffold microstructure. Together, these properties effectively activate the body’s intrinsic healing mechanisms, making amniotic tissue one of the most promising natural biomaterials in modern regenerative medicine.
AmnioLink® is developed under the authorization of the Ministry of Health and Welfare (MOHW) for the establishment of a Human Organ Preservation Bank and is GTP-certified in Taiwan. The product is manufactured in accordance with the American Association of Tissue Banks (AATB) technical standards. Through comprehensive donor blood screening, decellularization, and sterilization processes, AmnioLink® exceeds international tissue bank quality standards, ensuring exceptional clinical safety and biological activity. It serves as a powerful tool for physicians in the field of tissue repair and regenerative therapy.
ECM Biomedical’s amniotic product line is available in two formulations:
- Amnion Full Thickness Double Layer, and
- Amnion For Minimally Invasive Surgery.
During surgery, the amniotic sheet can be applied directly to the affected site, or the matrix can be delivered via minimally invasive techniques to the target tissue. Through a controlled-release mechanism, growth factors are gradually released to suppress local inflammation, relieve pain, promote tissue regeneration, and facilitate soft tissue repair.
coming soon
